Pharmacy companies welcome deregulation of OTC medicines

Published: 2011-06-17 06:59:00

Updated: 2011-06-17 06:59:00

With the government’s announcement yesterday to reclassify 44 over-the-counter (OTC) medicines as quasi-drugs that can be purchased anywhere, such as convenience stores and supermarkets, pharmaceutical companies welcome the deregulation as it could widen the sales network and lower their entry ba...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK